CR Sanjiu(SZ:000999) Nan Fang Nong Cun Bao·2026-01-08 14:35Core Viewpoint - The integration of AI technology is driving a transformation in the traditional Chinese medicine (TCM) industry in Guangdong, with the establishment of two specialized committees focusing on classic prescriptions and the synergy between medicine and food [1][4]. Group 1: Industry Development and Achievements - The Guangdong Provincial Chinese Medicine Association held its second member representative conference, emphasizing the theme "AI Empowering New Business Formats, Leading New TCM" [2][3]. - The TCM industry in Guangdong has seen steady growth, with over 370 TCM production enterprises and more than 4,780 approved TCM products as of the end of 2025 [10][11]. - The province has approved 7 new TCM drugs and added 8 new national TCM protected varieties, maintaining a strong position nationally [12]. Group 2: Key Initiatives and Standards - During the "14th Five-Year Plan" period, Guangdong has implemented five key measures to strengthen the industry foundation, including the compilation of standards for TCM materials and the release of 479 standards for granule prescriptions [15][16]. - The establishment of the "Quality Management Norms for TCM Distribution and Preparation Bases" aims to address the growing demand for TCM preparation and distribution services [39][40]. Group 3: AI and Technological Integration - The conference highlighted the deep integration of AI and genomics in TCM innovation, with significant breakthroughs presented by experts in the field [26][27]. - The development of a gene coding library for natural drug components is expected to enhance the precision and efficiency of new drug screening [28][29]. Group 4: Specialized Committees and Collaborative Efforts - Two specialized committees were established: one for classic prescriptions and another for the synergy between medicine and food, aimed at promoting industry development and standardization [33][34]. - The committees are expected to facilitate practical research and industry assessments, contributing to the growth of the TCM sector in Guangdong [36][38]. Group 5: Future Directions and Goals - The Guangdong Provincial Drug Administration is leading the formulation of policies for high-quality development in the pharmaceutical and medical device industries, with a focus on AI applications in drug regulation [21][22]. - The association aims to continue serving as a bridge for the industry, focusing on innovation and quality as it moves into the new development phase of the "14th Five-Year Plan" [64][66].